Servicio de Cirugía General y de Aparato Digestivo, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, España.
Servicio de Cirugía General y de Aparato Digestivo, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, España; Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, España; Departamento de Cirugía, Pediatría y Obstetricia y Ginecología, Universidad de Murcia, Murcia, España.
Endocrinol Diabetes Nutr (Engl Ed). 2020 May;67(5):317-325. doi: 10.1016/j.endinu.2019.09.012. Epub 2019 Dec 24.
The incidence of papillary thyroid microcarcinoma (PTMC) has increased in recent years, especially in patients operated on for presumably benign thyroid disease. The aim of this study was to analyze the differences between PTMC incidentally diagnosed and PTMC clinically diagnosed, as well as its long-term prognosis.
The study population consisted of patients with a histological diagnosis of PTMC. Patients with previous thyroid surgery, other synchronous thyroid or extrathyroid malignancies and an ectopic location of PTMC were excluded. Two groups were compared: patients with PTMC incidentally diagnosed (group 1) and patients with PTMC clinically diagnosed (group 2). A multivariate analysis of differentiating factors was performed.
PTMC clinically diagnosed had a high frequency of hypothyroidism (4.6% vs. 18.9%; P=.004), extrathyroidal extension (5.7% vs. 17.6%; P=.018), metastatic lymph nodes (1.1% vs. 18.9%; P<.001) and lymphocytic thyroiditis (5.7% vs. 27%; P<.001). In the multivariate analysis, metastatic lymph nodes (OR: 22.011, IC 95%: 2.621-184.829; P=.004) and lymphocytic thyroiditis (OR: 4.949; IC 95%: 1.602-15.288; P=.005) were associated with the clinical diagnosis of PTMC. During a mean follow-up of 119.8±65.1 months, one recurrence was detected in group 2 (0% vs. 1,4%; P=.460). No patient died due to the disease.
PTMC clinically diagnosed, although it has more aggressive histopathological characteristics (extrathyroidal extension and metastatic lymph nodes), presents a long-term prognosis similar to the PTMC incidentally diagnosed. The presence of metastatic lymph nodes and lymphocytic thyroiditis were independent factors associated with PTMC clinically diagnosed.
近年来,甲状腺微小乳头状癌(PTMC)的发病率有所增加,尤其是在因疑似良性甲状腺疾病而接受手术的患者中。本研究旨在分析偶然诊断的 PTMC 与临床诊断的 PTMC 之间的差异及其长期预后。
研究人群包括组织学诊断为 PTMC 的患者。排除既往甲状腺手术、其他同时性甲状腺或甲状腺外恶性肿瘤以及 PTMC 异位的患者。比较两组患者:偶然诊断的 PTMC 患者(组 1)和临床诊断的 PTMC 患者(组 2)。对鉴别因素进行多变量分析。
PTMC 临床诊断组甲状腺功能减退症的发生率较高(4.6%比 18.9%;P=.004)、甲状腺外侵犯(5.7%比 17.6%;P=.018)、转移性淋巴结(1.1%比 18.9%;P<.001)和淋巴细胞性甲状腺炎(5.7%比 27%;P<.001)。多变量分析显示,转移性淋巴结(OR:22.011,95%CI:2.621-184.829;P=.004)和淋巴细胞性甲状腺炎(OR:4.949;95%CI:1.602-15.288;P=.005)与 PTMC 的临床诊断有关。在平均 119.8±65.1 个月的随访期间,组 2 中仅发现 1 例复发(0%比 1.4%;P=.460)。没有患者因疾病死亡。
虽然临床诊断的 PTMC 具有更具侵袭性的组织病理学特征(甲状腺外侵犯和转移性淋巴结),但其长期预后与偶然诊断的 PTMC 相似。转移性淋巴结和淋巴细胞性甲状腺炎的存在是与临床诊断的 PTMC 相关的独立因素。